Adenosine-A1 Receptors Activation Restores the Suppressed Cardioprotective Effects of Ischemic Preconditioning in Hyperhomocysteinemic Rat Hearts
Authors:
- Pitchai BalakumarPBPitchai Balakumar
- Harsimran SinghHSHarsimran Singh
- Krishna ReddyKRKrishna Reddy
- Madhu B Anand-SrivastavaMAMadhu B Anand-Srivastava
- 1 September 2009
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 54 (3) , 204-212
Abstract
We have previously shown that the cardioprotective effect of ischemic preconditioning (IPC) is suppressed in hyperhomocysteinemic rat hearts. The present study investigated the effect of 2-chloro-N-cyclopentyladenosine (CCPA), a selective adenosine-A1 receptor agonist, in hyperhomocysteinemia-induced attenuation of the cardioprotective effect of IPC. Rats were administered L-methionine (1.7 g/kg/day po) for 8 weeks to produce hyperhomocysteinemia. Isolated Langendorff perfused normal and hyperhomocysteinemic rat hearts were subjected to 30-minute global ischemia, followed by a 120-minute reperfusion. Myocardial infarct size was assessed macroscopically using triphenyltetrazolium chloride staining. Coronary effluent was analyzed for lactate dehydrogenase and CK-MB release to assess the extent of cardiac injury. The oxidative stress in the heart was assessed by measuring thiobarbituric acid reactive substance and reduced form of glutathione. Ischemia and reperfusion (I/R) produced myocardial injury by increasing myocardial infarct size, elevating lactate dehydrogenase and CK-MB release in coronary effluent, decreasing coronary flow rate, and inducing oxidative stress in normal and hyperhomocysteinemic rat hearts. The hyperhomocysteinemic rat hearts showed enhanced I/R-induced myocardial injury with high oxidative stress. The IPC afforded cardioprotection against I/R-induced myocardial injury in normal rat hearts. However, IPC-mediated myocardial protection against I/R injury was abolished in hyperhomocysteinemic rat hearts. Administration of CCPA did not alter the cardioprotective effect of IPC in normal rat hearts, but its administration markedly restored the cardioprotective effect of IPC in hyperhomocysteinemic rat hearts. It may be concluded that the activation of adenosine-A1 receptors using CCPA markedly restored the suppressed cardioprotective and infarct size-limiting effects of IPC in hyperhomocysteinemic rat hearts. Thus, the reduced availability of extracellular adenosine and impaired activation of adenosine-A1 receptors may be responsible for abolishing the cardioprotective potential of IPC against I/R-induced myocardial injury in hyperhomocysteinemic rat hearts.Keywords
This publication has 47 references indexed in Scilit:
- Preconditioning and postconditioning: Underlying mechanisms and clinical applicationAtherosclerosis, 2009
- Pre-conditioning and postconditioning to limit ischemia–reperfusion-induced myocardial injury: What could be the next footstep?Pharmacological Research, 2008
- Inhospital cardiovascular morbidity and mortality in the department of internal medicine at CHU Kigali (Rwanda)Annals of Tropical Medicine and Public Health, 2008
- Signaling Mechanisms in Ischemic PreconditioningCirculation Research, 2006
- Survival kinases in ischemic preconditioning and postconditioningCardiovascular Research, 2006
- Preconditioning the Myocardium: From Cellular Physiology to Clinical CardiologyPhysiological Reviews, 2003
- Myocardial KATPChannels in PreconditioningCirculation Research, 2000
- Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart?Trends in Pharmacological Sciences, 2000
- Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injuryAmerican Journal of Physiology-Heart and Circulatory Physiology, 1993
- Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation, 1986